Locations:
SearchDr. Steven Nissen shares why these studies matter
The recent European Society of Cardiology (ESC) 2016 Congress may have been short on headline-grabbing trials, but that doesn’t mean there weren’t study presentations with very important implications for many, many patients.
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Two such studies — the NORSTENT comparison of drug-eluting and bare-metal coronary stents, and a fascinating analysis out of Wayne State University evaluating long-term exposure to low levels of both LDL cholesterol and blood pressure — stood out for Cleveland Clinic Cardiovascular Medicine Chairman Steven Nissen, MD.
In this short video, Dr. Nissen explains how and why each study matters to cardiovascular practice.
Advertisement
Advertisement
A sampling of outcome and volume data from our Heart & Vascular Institute
Concomitant AF ablation and LAA occlusion strongly endorsed during elective heart surgery
Large retrospective study supports its addition to BAV repair toolbox at expert centers
Young age, solid tumor, high uptake on PET and KRAS mutation signal risk, suggest need for lobectomy
Surprise findings argue for caution about testosterone use in men at risk for fracture
Residual AR related to severe preoperative AR increases risk of progression, need for reoperation
Findings support emphasis on markers of frailty related to, but not dependent on, age
Provides option for patients previously deemed anatomically unsuitable